Physician profile
Brian Desmond
NPI 1972591865
$1,822.62
in general payments reported to CMS, 2019-2025
31 companies · $76.37 in 2025
The $76.37 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,296 · 2020: $153 · 2021: $22.65 · 2022: $114 · 2023: $37.51 · 2024: $124 · 2025: $76.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $238.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $298.20 | 2019-2025 | Arexvy, Shingrix |
| Allergan, INC. | $197.69 | 2019-2020 | |
| Pfizer INC. | $195.93 | 2019-2020 | |
| Novo Nordisk INC | $177.38 | 2019-2020 | |
| Senseonics, Incorporated | $122.00 | 2019 | |
| Lilly USA, LLC | $78.25 | 2019-2022 | |
| Amgen INC. | $72.43 | 2019 | |
| Mannkind Corporation | $66.38 | 2019 | |
| Sanofi-Aventis U.S. LLC | $57.71 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $48.37 | 2019 | |
| Ascensia Diabetes Care US INC. | $48.32 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $45.77 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $44.43 | 2022 | |
| Dexcom, INC. | $41.96 | 2019 | |
| Sanofi Pasteur INC. | $40.87 | 2019-2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $38.67 | 2019 | |
| Shire North American Group INC | $24.83 | 2019 | |
| Advanced Respiratory, INC | $20.35 | 2019 | |
| Vifor Pharma, INC. | $19.89 | 2019 | |
| Amarin Pharma, INC. | $18.53 | 2019 | |
| Mylan Specialty L.P. | $16.73 | 2019 | |
| Daiichi Sankyo INC. | $16.49 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.23 | 2019 | |
| Arbor Pharmaceuticals, INC. | $15.48 | 2019 | |
| Edwards Lifesciences Corporation | $15.45 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.31 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.86 | 2020 | |
| Therapeuticsmd, INC. | $14.75 | 2019 | |
| Emd Serono, INC. | $14.54 | 2019 | |
| Companion Medical, INC. | $13.55 | 2020 | |
| Vertiflex, INC. | $11.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Desmond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.